Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells
Autor: | Pamela L. Rice, Lori R. Kisley, Jason M. Fritz, Bradley S. Barrett, Mary C. Srebernak, Alvin M. Malkinson, Lori D. Dwyer-Nield |
---|---|
Rok vydání: | 2010 |
Předmět: |
Pulmonary and Respiratory Medicine
MAPK/ERK pathway medicine.medical_specialty Kinase medicine.medical_treatment Clinical Biochemistry Prostanoid Biology Proinflammatory cytokine chemistry.chemical_compound Cytokine Endocrinology chemistry Internal medicine medicine Cancer research Tumor necrosis factor alpha Interferon gamma Protein kinase A Molecular Biology medicine.drug |
Zdroj: | Experimental Lung Research. 36:558-571 |
ISSN: | 1521-0499 0190-2148 |
DOI: | 10.3109/01902148.2010.491891 |
Popis: | The inflammatory cytokines tumor necrosis factor alpha (TNFα) and interferon gamma (IFNγ) stimulate production of the inflammatory mediators prostaglandin E₂ (PGEγ), prostacyclin (PGIγ), and nitric oxide (NO) in cultured lung epithelial cells. Pretreatment of these cells with the selective MEK1/2 (mitogen-activated protein kinase/extracellular signal-regulated kinase [ERK] kinase 1/2) inhibitor U0126 blocked ERK1/2 activation and inhibited cytokine-induced production of these inflammatory mediators. Primary bronchiolar epithelial Clara cells treated with TNFα and IFNγ also produced increased PGE₂, PGI₂, and NO, and PG and NO production was decreased by MEK inhibition. U0126 differentially affected cyclooxygenase (COX)-1, COX-2, and inducible NO synthase (iNOS) expression in cell lines, however, suggesting that MEK1/2 regulates prostanoid and NO production by means other than inducing their biosynthetic enzymes. Functionally, inhibition of MEK1/2 caused G1 cell cycle arrest and decreased cyclin D1 expression, but these effects were not related to decreased prostanoid production. These results indicate separate proinflammatory and proliferative roles for ERK1/2 in lung epithelial cells. During lung tumor formation in vivo, ERK1/2 phosphorylation increased as lung tumors progressed. Since tumor-derived cells were more sensitive than nontumorigenic cells to the antiproliferative effects of U0126, MEK1/2 inhibition may serve as an attractive chemotherapeutic target. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |